Hepatitis C NS4A inhibitors belong to a specific chemical class of compounds that target the NS4A protein in the Hepatitis C virus (HCV). NS4A is a crucial non-structural protein that plays a significant role in the replication and maturation of the virus. The inhibitors are designed to specifically interact with NS4A, disrupting its function and hindering the virus's ability to replicate and propagate within the host cells. By interfering with this essential viral protein, Hepatitis C NS4A inhibitors aim to impede the virus's life cycle and limit its ability to cause further infection.
These inhibitors are characterized by their specific molecular structure, which enables them to bind tightly to the NS4A protein, thereby modulating its activity. Research and development in this chemical class have focused on understanding the molecular interactions between the inhibitors and NS4A, as well as optimizing their pharmacological properties to enhance their potential effectiveness against Hepatitis C.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Simeprevir | 923604-59-5 | sc-473928 sc-473928A | 5 mg 50 mg | $302.00 $2081.00 | ||
This is a once-daily NS3/4A protease inhibitor investigated for HCV genotype 1 infection, in combination with other antiviral agents. | ||||||
Danoprevir | 850876-88-9 | sc-364480 sc-364480A | 5 mg 50 mg | $320.00 $1950.00 | ||
Danoprevir is an investigational NS3/4A protease inhibitor. | ||||||